Theme: New Developments in Psychiatry & Mental health- Empower, Engage, Educate

Psychiatry and Psychosomatic Medicine 2022

Psychiatry and Psychosomatic Medicine 2022

ConferenceSeries is a renowned organization that organizes highly notable Psychiatry conferences throughout the globe.

ConferenceSeries is currently bringing forth "33rd International Conference on Psychiatry & Psychosomatic Medicine(psychiatry and Psychosomatic Medicine 2022) slated on December 19-20, 2022, Rome, Italy. The main theme of our conference is “New Developments in Psychiatry & Psychosomatic Medicine- Empower, Engage, Educate”our conference mission is to train and support psychiatrists and other mental health professionals to provide quality care and leadership. Its thought provoking, high quality work, involving mental illness and psychological disorders. Psychiatry is the branch of medicine focused on the diagnosis, treatment and prevention of mental, emotional and behavioral disorders. Psychosomatic medicine may be defined as a comprehensive, interdisciplinary framework for: assessment of psychological factors affecting individual vulnerability as well as course and outcome of illness; bio psychosocial consideration of patient care in clinical practice; specialist interventions to integrate psychological therapies in the prevention, treatment and rehabilitation of medical disease. Subsequently, this conference has invaluable insight for psychiatrists, therapists, clinical social workers, psychotherapists and all researchers in the field of Psychosomatic Medicine. The main objective of the conference is to serve a forum for scientists, researchers, physicians, Surgeons and other health professionals to find current advances in the areas of Psychiatry and Psychosomatic Medicine Research.

2022 Highlights:

  • 200+ Participation (70% Industry: 30% Academia)
  • 9+ Keynote Speakers
  • 30+ Plenary Speakers
  • 3+ Exhibitors
  • 14 Innovative Educational Sessions
  • B2B Meetings


Why exhibit?

  • Make sales
  • Debut new products
  • Profile your brand
  • Meet new business partners and suppliers
  • Develop key relationships
  • Educate healthcare, pharma and biotech institutions and academia

Who you will meet?

  • Psychiatrists
  • Neuropsychologists
  • Neuropsychiatrists
  • psychologists
  • Neurologists
  • Neurosurgeons
  • Neuroradilogists
  • Neurospecialists
  • Neuroscientists
  • Paediatric Neuropsychologist
  • Cognitive Neuropsychologist
  • Psychobiologist
  • Psychophysicist
  • Biological Psychologist
  • Psychiatric social workers
  • Psychiatric nurse practitioners
  • Behavioral health administrators
  • Primary care providers

Who should sponsor?

  • Pharmaceuticals
  • Drug Manufacturers
  • Hospitals
  • Educational Institutes
  • Research Centres


Psychiatry is a branch that diagnoses treatment and prevention of mental, emotional and behavioural disorders. Psychiatrists are the experts treating mental illness. Schizophrenia, depression, bipolar disorders, eating disorders etc., are the mental health conditions. Psychiatrists provide psychological treatment, medication, brain stimulation technique such as electroconvulsive therapy. 2.8% of adults nearly affect with mental health disorders

Track2: Child and Adolescent psychiatry

Child and Adolescent psychiatry is a branch of psychiatry that focusses on diagnosis, treatment and prevention of mental disorders in children and adults. Child psychiatry is otherwise called Paediatric psychiatry tremendous developments have been seen in the past two decades child and adolescent psychiatry is a challenging speciality. 75% of adult mental health problems have been started before the age of 18. ADHD, Autism is the neurodevelopmental disorders arising in childhood disruptive behaviour, feeding and toileting difficulties, depression are the emotional Disorders.

Track3: Mental illness and Health Care

Mental illness is called mental health disorders it affects persons thinking, mood. One in five adults experience mental health disorders. Some disorders like autism or conduct disorder have significant implications for the child's development and modification in grown-up life. It examines the bio psychosocial factor that impacts the improvement and course of mental issue and treatment reaction to different intercessions.

Track4: Midwifery and Women’s Health

Midwifery is the science that deals with pregnancy, child birth and the care of new born Midwives are group of people who attend birth in and out of hospital they also provide well women care to clients between ages of 13 and 65. If the women risk status increases during pregnancy midwives work in close cooperation with physicians to develop and provide safest care plan. Women have unique health issues such as pregnancy, menopause, breast cancer, cervical cancer, bone density etc.

Track5: Mental health and Psychiatric Nursing

Mental health refers to our cognitive, behavioral, and emotional wellbeing. Biological factors like genes or brain chemistry, life experiences such as trauma or abuse, family history of mental health problems are the factors which contribute to mental health problems. People with these mental health problems can get better and recover easily. Psychiatric Nursing is the position of a nurse appointed who was specialised in mental health to help the patients overcome their psychiatric disorders and the stigma associated with it living their best lives. Psychiatric Nurses will work in Hospitals, Psychiatric Hospitals, Home healthcare organisations, prisons, Outpatient mentalhealth organisations and schools that serve people with emotional and mental health issues Nursing and mental health

Track6: Neuroscience and Neuropsychiatry

Neuroscience is the study of the brain and nervous system in both humans and non-human animals, and in both health and disease. The subject neuroscience has grown rapidly and now covers multiple areas including novel technologies and research into many brain functions and disorders, as well as applications as diverse as education, artificial intelligence and the law. Invasive Monitoring, Neuropsychological Testing, Eye-Tracking, Event-Related-Potentials, Kinematics, structural MRI, functional MRI, Tractography, Source EEG are some of the techniques in Neuroscience and Neuropsychiatry. Clinical Neuropsychiatry is the area of overlap between neurology and psychiatry and includes neurodegeneration, neuroinflammation, epilepsy, brain injury and functional neurological disorders. It is an exciting and developing area of study.

Track7: Addiction and its Disorders

Addiction is a complex condition, a brain disease that is manifested by compulsive substance use despite harmful consequence. It is difficult to control the use of the substance by a person with substance use disorder. Opioid Use Disorder, Gambling Disorder, Internet Gaming Disorder, Caffeine Intoxication and Withdrawal are some of the addiction disorders. Addictions are diagnosed under the category substance use and addiction disorders. Substance use disorders have a range of psychological, physical, and social effects that can drastically reduce people's quality of living

Track8: Schizophrenia and Nursing Care

Schizophrenia refers to a group of severe, disabling psychiatric disorders marked by withdrawal from reality, illogical thinking, possible delusions and hallucinations, and emotional, behavioral, or intellectual disturbance. It affects 1.1% of the population above age 18, which is estimated to be 51 million people worldwide. Schizophrenia is linked to many factors the exact cause is unknown. Nursing cares provide 24hr support. Nursing care usually refers to procedures or medications that area unit only or primarily geared toward providing comfort to a patient or assuaging that person’s pain, symptoms or distress, and includes the offer of oral nutrition and hydration.

Track9: Stress, Anxiety and Depression

Stress is that the response to a threat in an exceedingly state of affairs anxiety is that the reaction to fret. Chronic stress will have an effect on your health, inflicting symptoms from headaches, high vital sign, and pain to heart palpitations, skin rashes, and loss of sleep. Chronic anxiety will be weakening and cause irrational thoughts and fears that interfere together with your lifestyle. Depression and anxiety will occur at identical time. In fact, it’s been calculable that forty five % of individuals with one mental state condition meet the standards for 2 or a lot of disorders

Track10: Sleep Disorder and Medicine

Sleep is a complex biological process. While you are sleeping, you are unconscious, but your brain and body functions are still active. Insomnia, Sleep apnea, Restless leg syndrome, Hypersomnia, Circadian rhythm disorders, Parasomnia are some of the major sleep disorders. Mental illness line Depression and Anxiety, Nerve disorders can cause sleep disorders. Anti-Parkinsonian drugs, Benzodiazepines, Non-benzodiazepine hypnotics, Melatonin receptor stimulator, Opiates, Anticonvulsants, Anti-narcoleptics, Orexin receptor antagonists are some of the drugs used in the treatment of sleep disorders

Track11: Psychosis, Medication and Early Intervention

Psychosis is a mental health problem that causes individuals to interpret things around them. Hallucinations and Delusion are the symptoms of psychosis the combination of these two can cause severe distress and change in behaviour. Antipsychotics are given to reduce the symptoms of psychosis. These medications have serious side effects combination of these medicines with other therapies can help people to improve the quality of life

Track12: Research, Education and Case studies on Mental Health

According to world Health Organization (WHO), there are in excess of 450 million people with mental, neurological, or social issues far and wide (WHO, 2005a). Mental health issues are evaluated to speak to 13% of the overall weight of infection, essentially from unipolar and bipolar confusion, alcohol and substance-use disarranges schizophrenia, and dementia. Regardless, in various countries, passionate health is agreed a low need; for example, a 2005 WHO examination found that around 33% of low-pay countries who itemized a mental prosperity spending plan spent under 1% of their total prosperity spending plan on enthusiastic wellbeing.

Track13: Management and treatment of Mental Health issues

Many individuals determined to have psychological sickness accomplish quality and recuperation through taking an interest in individual or gathering treatment. There are a wide range of treatment alternatives accessible. There is no treatment that works for everybody – people can picked the treatment, or combination of medications, that works best. Treatments include psychotherapy, medication, hospitalisation, case management etc.

Track14: Psychosomatic medicine

Psychosomatic Medicine is the area of Psychiatry concerned with the psychobiological care of the medically ill. This patient population includes persons of all ages and those cared for in specialized settings such as internal medicine, surgery, organ transplantation, and many others. Psychosomatic Medicine specialists, in addition to providing expert formal psychiatric consultation to medical and surgical patients in the general hospital, specialized hospitals and outpatient clinic settings, also train psychiatrists and non-psychiatrist healthcare providers (e.g., internists, neurologists, surgeons, nurses, physician assistants) in the recognition of normal and abnormal reactions to illness and appropriate psychological care of patients with such reactions.It is an interdisciplinary field that is concerned with the interaction between biological, psychological, and social factors in regulating the balance between health and diseases like stress, emotion, Concepts, Cognition and Behavior.

  • Understand and master the rapid and dramatic changes in the practices of psychiatry and behavioral health.
  • Learn about clinical innovations to improve patient care.
  • Identify and improve mental health disparities in the community.
  • Network with colleagues and share solutions to the challenges you face.
  • Earn 10-15 CME credits.
  • Meet and network with the leaders in psychiatry and Psychosomatic Medicine and related disorders.
  • Participate in career Development sessions.
  • Share experiences, insights and strategies in interactive peer-to peer round tables.
  • Hear more perspectives in one place – from large medium and small organisations from Pharma, biotech and academia.
  • Learn about new treatment options to help your patients.


Al Baraha Global Psychiatry and Psychology market contributes to $34.5 billion which includes major countries such as US (74%), Europe (64%), japan (8.3%), and UAE (7.8%).

Market Analysis for Abuse and Addiction Treatment

Substance Abuse Treatment Market size was valued at USD 10 Billion in 2020 and is projected to reach USD 18.7 Billion by 2028, growing at a CAGR of 8% from 2021 to 2028.

Market Analysis for Pediatric Medicines

The global pediatric market should grow from $92.6 billion in 2019 to reach $116.6 billion by 2024 at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2024.

Market Analysis of Anti-Psychotic Drugs

The global antipsychotic drugs market size was valued at $12,417.60 million in 2020, and is estimated to reach $26,041.00 million by 2030, growing at a CAGR of 8.0% from 2021 to 2030. Antipsychotic drugs are medications used in treatment of psychosis including schizophrenia and bipolar disorder.

Market Analysis for CNS Biomarker Market

The central nervous system biomarkers market is projected to register a CAGR of 7.5% during the forecast period, with revenue of approximately USD 4,652 million in 2020, and it is expected to reach USD 7,160 million by 2026. COVID-19 cases across the world had a profound impact on the CNS biomarkers market.

Fund Allotment to Psychiatry Research

NIHR- National Institute for Health Research- $1.05 bi

HBP- Human Brain Project - $ 1.3bi

BRI- Brain Research Initiative -$ 0.1 bi

The total cost of treatment of anxiety and depression disorders across 36 countries worldwide is estimated to be $147 billion by 2030. The National Institute of Mental Health (NIMH) is the largest funder of research on mental disorders in the world. Mental illness’ and ‘Mental disorder’ are the terms used to describe a spectrum of mental health and behavioral disorders in Australia. National Survey of Mental Health and Wellbeing was started in 1990 in Australia. The role of this survey is to measure the number of population and the amount of disability with mental health disorders and mental health services used by the people. The importance of fine mental state and its impact on Australians have long been recognized by the Australian government and every one state and territory governments. Over the last three decades, these governments have worked along, via the National Mental State Strategy, to develop mental state programs and services to raised address the mental state needs of Australians.

In 2015-16, Australian Institute of Health and Welfare was estimated that around $9.0 billion or $373 per person was spent on mental health-related services. Out of 9.0 billion USD $5.4 billion (59.8%) was funded by state and territory governments, $3.1 billion (35%) were funded by the Australian government and $466 million (5.2%) was funded by private health insurance funds.

Funding of Projects

Brain Research Initiative

Brain Research through Advancing Innovative technology is a research effort launched by the Obama Administration to map the human brain working. In FY 2014, a $100 million fund was issued in name of the National Institutes of Health.

National Institute for Health Research

In 2012/13, NIHR had a total research cost of £958.9m, research program’s- £208.9m and on infrastructure-£618.9m. The Faculty members of NIHR including senior investigators and fellowships received £100m.

Human Brain Project

The Human Brain Project is the one of the longest running project; the project cost is estimated at 1.19 billion euros and planned to last ten years (2013-2023).


Psychiatrists - Demand for Psychiatrists are projected to increase from ∼18,180 to 21,440 by 2025.

The Human Brain Project- The main goal of the HBP is to deliver a collaboratively built first draft "scaffold" model and simulation of the human brain by 2023.

Healthy People 2020- It is a statement of national health objectives designed to identify the most significant preventable threats to health and to establish national goals to reduce these Psychiatry problems.

WPA Member Societies and Sections plan to increase significantly the number of Psychiatrists in the near future, and to upgrade the pattern of distribution of the journal. In addition to the original English edition, a Chinese edition of the journal is already being produced. Contacts are ongoing for the production of Spanish, a Portuguese and a Japanese edition.

The journal is also produced in an electronic version, which is sent by email to the Presidents of all WPA Member Societies and the Chairpersons of all WPA Sections. This version is already included in the website of the WPA and of several of its Member Societies and Sections.

Global Burden of Disease: A collaborative Project (2005 to 2030)

WHO launched a number of global public health projects, including the Public Health and Global Initiative on Psychiatry and whose purpose is to increase professional and public awareness of the occurrence, extent and costs of disorders and to emphasize the need to provide Psychiatric & psychological care at all levels including primary healthcare.

Human Connectome:

The NIH Human Connectome Project is an ambitious effort to map the neural pathways that underlie human brain function. The objective of Project is to acquire and share data about the structural and functional connectivity of the human brain.

ROOTS: Investigating the origins of adolescent psychopathology

The project will not restrict itself to the study of depression but will encompass many aspects of teenage mental health throughout the demanding adolescent period. The aim is to determine the relative contributions that specific genetic, physiological, psychological and social variables make to the overall risk for psychopathology during adolescence. Teenagers are recruited into the study at age 14 and will be followed through the adolescent period until they reach 17-18.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 19-20, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View